Principal Financial Group’s Mersana Therapeutics MRSN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,354
| Closed | -$3.56K | – | 2288 |
|
|
2025
Q1 | $3.56K | Buy |
+10,354
| New | +$3.56K | ﹤0.01% | 2170 |
|
|
2024
Q3 | – | Sell |
-18,278
| Closed | -$36.7K | – | 2345 |
|
|
2024
Q2 | $36.7K | Sell |
18,278
-13,497
| -42% | -$27.1K | ﹤0.01% | 2308 |
|
|
2024
Q1 | $142K | Sell |
31,775
-1,702
| -5% | -$7.63K | ﹤0.01% | 2230 |
|
|
2023
Q4 | $77.7K | Buy |
33,477
+1,726
| +5% | +$4K | ﹤0.01% | 2297 |
|
|
2023
Q3 | $40.3K | Buy |
31,751
+1,412
| +5% | +$1.79K | ﹤0.01% | 2361 |
|
|
2023
Q2 | $99.8K | Buy |
30,339
+4,877
| +19% | +$16K | ﹤0.01% | 2289 |
|
|
2023
Q1 | $105K | Buy |
25,462
+3,595
| +16% | +$14.8K | ﹤0.01% | 2295 |
|
|
2022
Q4 | $128K | Buy |
21,867
+2,947
| +16% | +$17.3K | ﹤0.01% | 2262 |
|
|
2022
Q3 | $128K | Buy |
18,920
+4,982
| +36% | +$33.7K | ﹤0.01% | 2284 |
|
|
2022
Q2 | $64K | Buy |
13,938
+2,769
| +25% | +$12.7K | ﹤0.01% | 2444 |
|
|
2022
Q1 | $45K | Buy |
11,169
+658
| +6% | +$2.65K | ﹤0.01% | 2490 |
|
|
2021
Q4 | $65K | Sell |
10,511
-15,502
| -60% | -$95.9K | ﹤0.01% | 2470 |
|
|
2021
Q3 | $245K | Sell |
26,013
-27
| -0.1% | -$254 | ﹤0.01% | 2375 |
|
|
2021
Q2 | $353K | Sell |
26,040
-55,116
| -68% | -$747K | ﹤0.01% | 2305 |
|
|
2021
Q1 | $1.31M | Buy |
81,156
+3,373
| +4% | +$54.6K | ﹤0.01% | 1936 |
|
|
2020
Q4 | $2.07M | Buy |
+77,783
| New | +$2.07M | ﹤0.01% | 1790 |
|